Sava Infond D.O.O. Abbott Laboratories Transaction History
Sava Infond D.O.O.
- $640 Billion
- Q2 2025
A detailed history of Sava Infond D.O.O. transactions in Abbott Laboratories stock. As of the latest transaction made, Sava Infond D.O.O. holds 34,200 shares of ABT stock, worth $4.23 Million. This represents 0.73% of its overall portfolio holdings.
Number of Shares
34,200
Previous 34,440
0.7%
Holding current value
$4.23 Million
Previous $4.57 Billion
1.82%
% of portfolio
0.73%
Previous 0.87%
Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,611Shares Held
1.4BCall Options Held
9.22MPut Options Held
8.09M-
Vanguard Group Inc Valley Forge, PA173MShares$21.4 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.2 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.4MShares$9.69 Billion0.41% of portfolio
-
Capital International Investors Los Angeles, CA60.1MShares$7.43 Billion1.47% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.8MShares$5.16 Billion1.19% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $216B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...